As adoption of GLP-1s continues to become more and more mainstream, this trend will only intensify
The limited data to date suggest that GLP1-RA may be a promising strategy for weight, glycaemic [blood sugar] and appetite control in PWS patients, at least in the short term, with no major adverse effects, the researchers concluded
Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase
Patients who began GLP-1 medications in late 2024 and 2025 are now reaching stable goal weights and seeking solutions for excess skin that diet and exercise cannot resolve
This might reflect the extensive GLP-1R degradation noted in Fig
Research suggests that it can improve sperm quality, motility, and overall reproductive function